Objective: To explore soy intake and urinary isoflavonoid excretion within several generations of American-Japanese women based on the hypothesis that earlier generations excrete higher levels of urinary isoflavonoids, in particular the metabolite equol, than later generations. Subjects: A convenience sample of 43 women from 19 families aged 18-78 years, all of whom reported at least 50% Japanese ancestry. Interventions: Each woman collected overnight urine samples at baseline and after consuming one serving of soymilk, both samples were analyzed for the isoflavonoids daidzein, genistein and equol using liquid chromatography-mass spectrometry. Results: Median isoflavone intakes during the last year were 7.2 mg/day for the first generation, 7.3 mg/day for the second generation and 6.3 mg/day for the third generation (P ¼ 0.36). At baseline, the median isoflavonoid excretion for the first generation was nonsignificantly higher than for later generations (190, 86 and 42 nmol/h; P ¼ 0.20) but after intervention, the median urinary isoflavonoid excretion was very similar for the three groups: 2465, 1895 and 2775 nmol/h (P ¼ 0.70). Following intervention, a nonsignificantly higher proportion of older than younger women (53 vs 32 and 33%; P ¼ 0.41) excreted the metabolite equol. The respective median equol excretion rates by generation following intervention were 39.5, 4.2 and 3.5 nmol/h (P ¼ 0.04). Conclusions: This small investigation among three generations of Japanese-Americans detected a higher equol production among older women after a soy challenge, but no difference in the excretion of total isoflavonoids after a standardized dose of soymilk was observed.
Introduction
Women in Japan have one of the lowest incidence rates of breast cancer in the world, but when they migrate to the United States, their risk increases significantly (Shimizu et al., 1991) . In recent years, breast cancer incidence in Japanese-American women has been approximately the same as for Caucasian women (Deapen et al., 2002; Pike et al., 2002) . The rising incidence rates among migrant women suggest that environmental factors such as diet may influence the development of breast cancer (Buell, 1973) . Soy foods were proposed as one of the possible sources of protection (Ziegler et al., 1993; Yan and Spitznagel, 2004) owing to their estrogenic and anti-estrogenic properties (Adlercreutz, 1995) . Most soy foods contain glycosides of the isoflavones daidzein, genistein and glycitein, which are hydrolyzed by intestinal glucosidases and absorbed as aglycones following ingestion (Coward et al., 1993; Wang and Murphy, 1994; Tsukamoto et al., 1995; Franke et al., 1998 Franke et al., , 2004 . The isoflavone daidzein is metabolized to equol and O-desmethylangolensin by intestinal bacteria (Axelson et al., 1984; Atkinson et al., 2004) . The extent of the metabolism seems to be highly variable among individuals and may be influenced by other components of the diet (Lampe et al., 1999; Rowland et al., 2000) . Approximately 30-50% of the human population produces equol (Setchell et al., 2002; Atkinson et al., 2005) , but it appears that a greater proportion of Asian than Western populations have the ability to produce equol (Setchell et al., 2002; Akaza et al., 2004; Ozasa et al., 2004) , possibly because they were exposed to soy early in life. Urinary isoflavonoid excretion serves as an excellent biomarker for soy intake owing to the rapid absorption and excretion of isoflavonoids specific to soy foods (Maskarinec et al., 1998) . Observational and intervention studies in humans have suggested that the ability to produce equol may be associated with a reduced risk for breast and prostate cancer (Setchell et al., 2002; Atkinson et al., 2005) . Women who consumed soy at least once per week during adolescence had a lower risk of breast cancer than women with less than monthly intakes during adolescence in two studies (Shu et al., 2001; Wu et al., 2002) . We hypothesized that women exposed to soy early in life, such as Japanese migrants, excrete higher levels of urinary isoflavonoids and are more likely to produce equol after consuming a standardized amount of soy than women of later generations who were exposed to a more Westernized diet. It has been proposed that intestinal bacteria are responsible for the differences in isoflavone metabolism (Atkinson et al., 2005) and that the development of gut bacteria may be influenced by habitual nutrition (Lampe et al., 1998; Rowland et al., 2000; Setchell et al., 2002) .
Subjects and methods

Participants
We recruited a convenience sample through employees, families and friends of our center. Eligible participants were at least 18 years old, English speaking, at least 50% Japanese ancestry, currently residing in Hawaii, free of known soy allergies and had at least one other female relative of a different generation willing to participate. Except for one young woman who was taking a very low dose acne treatment, no antibiotics were used during this study. The older women in the study group, the grandmothers, were over 60 years and older; the second-generation women, the mothers, were 30-59 years old and the third-generation participants were 30 years of age or younger. With the exception of four women who were born in Japan, also called Issei, the older generation women in this study were Nissei or Sansei, that is, children and grandchildren of Japanese immigrants to Hawaii who arrived during 1868 -1924 (Nordyke, 1989 . The study protocol was approved by the Committee on Human Subjects at the University of Hawaii; all participants gave written informed consent.
Data collection
Demographic, reproductive and medical information was collected by questionnaire. Regular soy intake was assessed with a 12-item questionnaire, which elicited the frequency and portion size of soy foods consumed during the last 12 months (Williams et al., 2003) . To obtain a summary score, we multiplied the frequencies of intake for each of the 12 soy foods by the estimated isoflavone content from the food composition database maintained by the Nutrition Support Shared Resource at the Cancer Research Center of Hawaii (Murphy, 2002) . The total amounts from all foods were added as an estimate of daily isoflavone intake. Isoflavone values (genistein, daidzein and glycitein) for soy foods in this database were largely derived from analyses of representative local foods (Franke et al., 1999) . A lifetime questionnaire estimated soy exposure since birth (Maskarinec et al., 2004) using the following periods: infancy (1 year), childhood (1-9 years), adolescence (10-19 years), early adulthood (20-29 years) and late adulthood (30 þ years). Participants marked the annual frequency (never, 1/month, 2-3/month, 1/week, 2-3/week, 4-6/week, 1/day and 2 þ /day) of four categories of soy foods (tofu, soy beans and sprouts, soybean drink or milk and other soy products) for each of the stages. For infancy, soy-based formula was the only choice. To obtain a summary score, we multiplied the frequency of intake for each of the four foods by the estimated isoflavone amount and added the total amounts of the four foods in each of the stages of life to determine an annual intake for each stage.
Intervention and urine collection
The 3-day study protocol included two overnight urine collections. On day 1, participants consumed their normal diet during the day, emptied their bladders at 1800 hours, abstained from all soy foods until the next morning, and collected all urine during the night and in the early morning. On day 2, the subjects followed the same protocol but also abstained from all soy foods other than one container of soymilk (8.45 fl oz. of Edensoy Original Organic Soymilk or Edensoy Extra Organic Soymilk) consumed after 1800 hours. The two types of soymilk were purchased at one time and only differed in their calcium content. Urine collection containers contained 0.1 g of ascorbic acid and 0.2 g of boric acid to prevent bacterial contamination and degradation of analytes. The urine samples were aliquoted and stored at À801C until analyzed. The samples from day 1 constituted the baseline measurements. Based on the collection times recorded by the subjects, we calculated the total number of overnight urine hours and assessed the completeness of overnight collection.
Urine analysis
Owing to budgetary constraints, only urinary daidzein, genistein and equol were analyzed by liquid chromatography-mass spectrometry (electrospray ionization, negative mode; ESI-MS) with photo diode array detection (PDA) using a LCQ Surveyor-Advantage system (ThermoElectron Corpor., Madison, WI, USA) (Franke et al., 2002; Blair et al., 2003) . In brief, triply 13 C-labeled internal standards of daidzein, genistein and equol (University of St Andrews, UK) were added to each specimen and hydrolyzed for 1 h at 371C with glucuronidase and sulfatase (Roche Applied Sciences, Indianapolis, IN, USA) followed by phase separation with diethyl ether . The ether fractions were dried under nitrogen and redissolved in a 1:1 mixture of methanol/NaAc buffer (0.2 M, pH 5). Ten microliters of this extract was analyzed by LC/PDA/ESI-MS after separation on a HydroBond PS (100 Â 3.0 mm; 5 mm) C18-reversed phase column coupled to a HydroBond PS C18 (20 Â 3.2 mm; 5 mm) direct-connect guard column (MacMod Analytical Inc., Chadds Ford, PA, USA). The elution, absorbance detection and mass spectrometric measurements were performed as applied previously (Franke et al., 2002; Adams et al., 2004; Cline et al., 2004) . Limits of quantitation for all analytes were 1.5 nmol/h for daidzein and genistein and 3.0 nmol/h for equol for post-intervention samples and half of those values for pre-intervention samples owing to differences in concentration steps before analysis. A woman with any measurable equol was considered an equol excretor. Between-day coefficients of variation ranged for in urine 4-12% (daidzein), 5-18% (genistein) and 3-14% (glycitein). Results were expressed as nmol/h of urine collection. The total number of hours covered by the urine collections was similar among subjects and did not warrant further adjustments.
Statistical analysis
We calculated descriptive statistics for the self-reported soy and isoflavone intakes and for urinary isoflavonoid excretion by generation. Because of our small sample size with distributions that deviated considerably from normality, medians rather than means were computed for isoflavone intake and urinary isoflavonoid excretion variables. For the same reason, differences between generations were assessed using the non-parametric Kruskal-Wallis test (SAS Institute Inc., 2004) . Soy intake during early and adult life was categorized into low and high using three servings per day as cutoff. We computed Spearman correlation coefficients (r s ) to explore the association between self-reported isoflavone intake and urinary excretion.
Results
We enrolled 19 families into the study (Table 1) : four families with three generations (grandmother, mother and daughter) and 15 families with two generations (10 families were generation 1 and 2, five families were generation 2 and 3). The age range was 18-78 years. Of the three-generation families, one included a paternal grandmother and one had two sisters. Most of the participants (41/43) were of full Japanese or Okinawan ancestry; one subject was halfJapanese (in addition to Chinese and Caucasian); and one Soy in Japanese-Americans G Maskarinec et al was three-fourth Japanese and one-fourth Korean. All women were apparently healthy. The most frequently eaten soy foods among all subjects were tofu, followed by soymilk, and then miso soup. Women in the first generation reported eating more tofu, fried tofu (e.g., the skin of deep fried tofu used to wrap rice for 'cone sushi'), miso paste, miso soup, soy nuts and natto, whereas women in the third generation reported eating more soy bars and meat analogs made from soy compared to the other age groups. The intake of soymilk was high in the second generation; eight out of 19 women consumed soymilk. Mean self-reported isoflavone intake during the previous year varied between 0.2 and 28.0 mg among families ( Table 1) . The median intake during the last year for the first generation was 7.2 mg/day, 7.3 mg/day for women in the second generation and 6.3 mg/day for the third generation (P ¼ 0.36). Among women in the first generation, 20% reported eating less than 5 mg/day of soy, whereas 47% of second-generation women and 44% of third-generation women consumed less than 5 mg/day. On the other hand, 40% of women in the first generation, 42% of women in the second generation and 11% of women in the third generation consumed more than 10 mg/day (P ¼ 0.32).
The urine samples were collected over 12.070.8 h at baseline and over 11.870.8 h after soymilk intake. At baseline, the median isoflavonoid excretion for the first generation was higher for the first than for the later generations (190, 86 and 42 nmol/h; P ¼ 0.20) (Figure 1 ), but this difference was not statistically significant. Selfreported soy intake during the last year and baseline urinary isoflavonoid excretion were weakly correlated (r s ¼ 0.28, P ¼ 0.07) for the overall population, but the relation was stronger for the first (r s ¼ 0.57, P ¼ 0.03) than for the second (r s ¼ 0.32, P ¼ 0.19) and third generation (r s ¼ À0.42, P ¼ 0.27). After intervention, the median urinary isoflavonoid excretion increased considerably, but it was very similar for the three groups: 2465, 1895 and 2775 nmol/h (P ¼ 0.70). There was also no significant difference in urinary isoflavonoid excretion after the soy challenge when we stratified by self-reported habitual soy intake at baseline (P ¼ 0.92). For women with less than 5 mg daily isoflavone intake, the median was 2211 nmol/h; for women with 5-10 mg of intake, it was 2538 nmol/h; and for women with intakes above 10 mg/day, it was 2332 nmol/h.
At baseline, 33% (5/15) of the first-generation women produced equol (Figure 2) , whereas 32% (6/19) of the women in the second generation and 33% (3/9) of women in the third generation produced equol at our detection limit (3.0 nmol/h). Following intervention, the respective proportions were 53, 32 and 33% (P ¼ 0.41). The respective median equol excretion rates by generation following intervention were 39.5, 4.2 and 3.5 nmol/h (P ¼ 0.04). There was no significant difference in habitual soy intake between women who produced equol and those who did not after the soy challenge (P ¼ 0.33), but the ratio between equol and daidzein, a measure of the ability to produce in relation to the available amount of its source daidzein, was Soy in Japanese-Americans G Maskarinec et al nonsignificantly higher for the first than for the later generations at any time. Self-reported soy intake during early life did not differ significantly by generation; the respective values were 1.8, 1.6 and 2.0 servings per week (P ¼ 0.87). After stratification by early life soy intake (Figure 3) , women with high intake (more than three servings per week) during early life had higher urinary isoflavonoid excretion at baseline (P ¼ 0.03). However, after intervention urinary excretion levels were very similar (P ¼ 0.32).
Discussion
Although the older Japanese-American women in our study excreted more isoflavonoids in urine than younger women, we observed no significant difference in urinary isoflavonoid excretion after a challenge of one serving of soymilk by generation or by self-reported soy intake during the previous year. The daidzein metabolite equol, which is produced by gut bacteria, was present after the intervention in a nonsignificantly larger proportion of women in the first than in the later generations. The small sample size of the study may have been responsible for the lack of statistical significance. However, the mean equol excretion levels were significantly higher for the first generation after the soy challenge. This suggests that the first generation may metabolize isoflavonoids differently from women in later generations owing to differences in early nutrition. Other explanations include older age because it is known that the composition of the gut flora changes with age (Saunier and Dore 2002; van Tongeren et al., 2005) or environmental factors that influence equol-producing gut bacteria (Lampe et al., 1999) . The fact that studied women from one family provides new insight into this issue because cross-sectional studies of unrelated subjects tend to be confounded by differences in diet and environment.
No differences were seen in soy intake between the generations. However, women in the first generation reported a higher consumption of traditional soy foods, such as tofu, miso soup, miso paste and natto, whereas the third generation consumed more of the 'Westernized' soy foods such as soy bars and meat analogs made from soy. The observation that the first generation showed the strongest correlation between self-reported intake and baseline urinary isoflavonoid excretion is probably a result of more accurate reporting of soy intake and possibly owing to more frequent and regular soy consumption. The negative correlation between self-reported intake and baseline urinary isoflavonoid excretion for the youngest generation is puzzling, but the skewed distribution of soy intake may have been responsible. Whereas one value was greater than 50 mg, all others were below 7 mg/day. The observation that 30% of our second-and third-generation subjects were equol producers agrees with published reports for Western populations (Lampe et al., 1998; Setchell et al., 2002; Frankenfeld et al., 2004) . Our finding that the older generation women excreted more equol after a soy challenge than younger women is consistent with equol producer rates of 50-60% reported from Japan (Akaza et al., 2004; Ozasa et al., 2004) . A significant higher prevalence of equol producers among Korean Americans than Caucasians (51 vs 36%; P ¼ 0.015) after a soy challenge also supports the idea that consumers of a traditional Asian diet metabolize isoflavones differently (Song et al., 2006) . As 41 out of 43 subjects reported 100% Japanese ancestry, ethnic admixture did not play a role in the differences.
The major limitation of this study was the small sample size. Because there were only four families of three generations, it was not possible to explore familial and genetic associations (Frankenfeld et al., 2004) . It would be beneficial to gather a larger random sample of Japanese-Americans to examine the relation by family and generation as long as Nissei or Sansei women are alive. Our recruitment strategy may have introduced selection bias; in particular, the younger women in the study may have consumed more soy than the average Japanese-American woman. The dietary assessment may have led to misclassification because the soy questionnaire may have been missing soy foods consumed in that age group. It is difficult to measure the accuracy of the lifetime soy questionnaire; it has not been validated so far and recall of dietary intake over so many years is challenging. The comparison of equol producer rates across studies is limited by the different urine collection protocols, analytical methods and detection limits.
Because all women were instructed to abstain from other soy foods, to consume the same amount of soymilk and to collect overnight urine, the recovery of isoflavonoids should have been comparable across age groups despite slight variations in the number of hours for which urine was collected. Urinary isoflavonoid excretion shows the highest correlation with recent soy intake owing to the fast pharmacokinetics of isoflavonoids (Setchell et al., 2003; Zubik and Meydani, 2003) . However, studies with large sample sizes that used validated diet questionnaires have consistently demonstrated significant associations in Asian and Western populations, even when urine was collected only once and soy intake was assessed over the previous year (Maskarinec et al., 1998; Seow et al., 1998; Chen et al., 1999; Atkinson et al., 2002) . This small investigation among three generations of Japanese-Americans observed a higher consumption of traditional Asian soy foods and a slightly higher equol production among older Japanese women, but no evidence that soy intake during early and adult life affected the ability to take up and excrete isoflavonoids after a standardized dose of soymilk. Although there is evidence that intestinal bacteria are responsible for the differences in isoflavone metabolism (Atkinson et al., , 2005 , not much is known about the determinants of gut bacteria and equol excretion status (Lampe et al., 1998; Rowland et al., 2000; Blair et al., 2003; Franke et al., 2004) or the possible effects of equol production on health outcomes.
